Spotlight on the new ACC/AHA lipid and JNC8 hypertension guidelines, EGFR inhibitors vs chemotherapy for NSCLC, and more.
JAMA Editors' Summary · American Medical Association
April 8, 20149m 33s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Editor's Audio Summary by Phil B. Fontanarosa, MD, MBA, Executive Editor, the Journal of the American Medical Association, for the April 09, 2014 issue